Bereich
Radio-Onkologie
RO · Dept. IV
Volumetric regression ratio of the primary tumor and metastatic lymph nodes after induction chemotherapy predicts overall survival in head and neck squamous cell carcinoma: a retrospective analysis
Elicin O, Giger R, Ghadjar P, Geretschlager A, Plasswilm L, Ambarcioglu P, Rauch D, Bromme J, Schmücking M, Aebersold D. Volumetric regression ratio of the primary tumor and metastatic lymph nodes after induction chemotherapy predicts overall survival in head and neck squamous cell carcinoma: a retrospective analysis. J BUON 2016; 21:175-81.
01.01.2016Volumetric regression ratio of the primary tumor and metastatic lymph nodes after induction chemotherapy predicts overall survival in head and neck squamous cell carcinoma: a retrospective analysis
01.01.2016J BUON 2016; 21:175-81
Elicin Olgun, Giger Roland, Ghadjar Pirus, Geretschlager Andreas, Plasswilm Ludwig, Ambarcioglu Pinar, Rauch Daniel, Bromme Jens, Schmücking Michael, Aebersold Daniel M
[Long-term sequelae after chemoradiation in head neck tumors]
Schoch M, Broglie Däppen M, Henke G, Stöckli S. [Long-term sequelae after chemoradiation in head neck tumors]. Ther Umsch 2016; 73:213-8.
01.01.2016[Long-term sequelae after chemoradiation in head neck tumors]
01.01.2016Ther Umsch 2016; 73:213-8
Schoch Manuel, Broglie Däppen Martina, Henke Guido, Stöckli Sandro
Erectile function following brachytherapy, external beam radiotherapy, or radical prostatectomy in prostate cancer patients
Putora P, Engeler D, Haile S, Graf N, Buchauer K, Schmid H, Plasswilm L. Erectile function following brachytherapy, external beam radiotherapy, or radical prostatectomy in prostate cancer patients. Strahlenther Onkol 2015; 192:182-9.
28.12.2015Erectile function following brachytherapy, external beam radiotherapy, or radical prostatectomy in prostate cancer patients
28.12.2015Strahlenther Onkol 2015; 192:182-9
Putora Paul Martin, Engeler Daniel, Haile S R, Graf N, Buchauer Konrad, Schmid Hans-Peter, Plasswilm Ludwig
Design and implementation of a "cheese" phantom-based Tomotherapy TLD dose intercomparison
Schiefer J. Design and implementation of a "cheese" phantom-based Tomotherapy TLD dose intercomparison. Strahlentherapie und Onkologie 2015; 191:855-861.
01.11.2015Design and implementation of a "cheese" phantom-based Tomotherapy TLD dose intercomparison
01.11.2015Strahlentherapie und Onkologie 2015; 191:855-861
Schiefer Johann
3d printed dose compensation body to remove dose artifacts of a HDR Brachytherapy surface applicator of the vertical type
Buchauer K, Plasswilm L, Schiefer J (2015). 3d printed dose compensation body to remove dose artifacts of a HDR Brachytherapy surface applicator of the vertical type.
21.10.20153d printed dose compensation body to remove dose artifacts of a HDR Brachytherapy surface applicator of the vertical type
21.10.2015SSRMP Annual Scientific Meeting 2015 (Fribourg)
Buchauer Konrad, Plasswilm Ludwig, Schiefer Johann
Reversible pure word deafness due to inferior colliculi compression by a pineal germinoma in a young adult
Joswig H, Schönenberger U, Brügge D, Richter H, Surbeck W. Reversible pure word deafness due to inferior colliculi compression by a pineal germinoma in a young adult. Clinical Neurology and Neurosurgery 2015; 139:62-65.
09.09.2015Reversible pure word deafness due to inferior colliculi compression by a pineal germinoma in a young adult
09.09.2015Clinical Neurology and Neurosurgery 2015; 139:62-65
Joswig Holger, Schönenberger U, Brügge Detlef, Richter Heiko, Surbeck Werner
Algorithms in the First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma-Analysis Using Diagnostic Nodes
Rothermundt C, Sternberg C, Schmidinger M, Rini B, Porta C, Oldenburg J, McDermott D, Larkin J, Grünwald V, Gillessen Sommer S, Escudier B, Eisen T, Cerbone L, Bailey A, Putora P. Algorithms in the First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma-Analysis Using Diagnostic Nodes. Oncologist 2015; 20:1028-35.
03.08.2015Algorithms in the First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma-Analysis Using Diagnostic Nodes
03.08.2015Oncologist 2015; 20:1028-35
Rothermundt Christian, Sternberg Cora, Schmidinger Manuela, Rini Brian, Porta Camillo, Oldenburg Jan, McDermott David, Larkin James, Grünwald Viktor, Gillessen Sommer Silke, Escudier Bernard, Eisen Tim, Cerbone Linda, Bailey Alexandra, Putora Paul Martin
PSA bounce after (125)I-brachytherapy for prostate cancer as a favorable prognosticator
Engeler D, Schmid H, Plasswilm L, Schiefer J, Stucki P, Suter S, Prikler L, Hochreiter W, Thöni A, Schwab C, Putora P. PSA bounce after (125)I-brachytherapy for prostate cancer as a favorable prognosticator. Strahlenther Onkol 2015; 191:787-791.
23.06.2015PSA bounce after (125)I-brachytherapy for prostate cancer as a favorable prognosticator
23.06.2015Strahlenther Onkol 2015; 191:787-791
Engeler Daniel, Schmid Hans-Peter, Plasswilm Ludwig, Schiefer Johann, Stucki Patrick, Suter Stefan, Prikler Ladislav, Hochreiter Werner, Thöni Armin F, Schwab Christoph, Putora Paul Martin
Design and implementation of a "cheese" phantom-based Tomotherapy TLD dose intercomparison.
Schiefer J, Buchauer K, Heinze S, Henke G, Plasswilm L. Design and implementation of a "cheese" phantom-based Tomotherapy TLD dose intercomparison. Strahlenther Onkol 2015; 191:855-61.
19.06.2015Design and implementation of a "cheese" phantom-based Tomotherapy TLD dose intercomparison.
19.06.2015Strahlenther Onkol 2015; 191:855-61
Schiefer Johann, Buchauer Konrad, Heinze Simon, Henke Guido, Plasswilm Ludwig
Re-irradiation or re-operation followed by dendritic cell vaccination? Comparison of two different salvage strategies for relapsed high-grade gliomas by means of a new prognostic model
Müller K, Hundsberger T, Kortmann R, Klautke G, Matuschek C, Friedrich C, Compter I, von Bueren A, De Vleeschouwer S, van Gool S, Pietschmann S, Henke G, Baumert B. Re-irradiation or re-operation followed by dendritic cell vaccination? Comparison of two different salvage strategies for relapsed high-grade gliomas by means of a new prognostic model. J Neurooncol 2015; 124:325-32.
13.06.2015Re-irradiation or re-operation followed by dendritic cell vaccination? Comparison of two different salvage strategies for relapsed high-grade gliomas by means of a new prognostic model
13.06.2015J Neurooncol 2015; 124:325-32
Müller Klaus, Hundsberger Thomas, Kortmann Rolf-Dieter, Klautke Gunther, Matuschek Christiane, Friedrich Carsten, Compter Inge, von Bueren André O, De Vleeschouwer Steven, van Gool Stefaan, Pietschmann Sophie, Henke Guido, Baumert Brigitta G
The SSRMP Tomotherapy Dosimetry Intercomparison 2014
Heinze S, Schiefer J, Buchauer K, Plasswilm L (2015). The SSRMP Tomotherapy Dosimetry Intercomparison 2014.
11.06.2015The SSRMP Tomotherapy Dosimetry Intercomparison 2014
11.06.2015SASRO
Heinze Simon, Schiefer Johann, Buchauer Konrad, Plasswilm Ludwig
Oesophageal cancer: exploring controversies overview of experts' opinions of Austria, Germany, France, Netherlands and Switzerland
Putora P, Stahl M, Schnider A, Mariette C, Van Lanschot J, Jäger R, van der Gaast A, Eisterer W, Budach W, Bedenne L, Ruhstaller T. Oesophageal cancer: exploring controversies overview of experts' opinions of Austria, Germany, France, Netherlands and Switzerland. Radiat Oncol 2015; 10:116.
21.05.2015Oesophageal cancer: exploring controversies overview of experts' opinions of Austria, Germany, France, Netherlands and Switzerland
21.05.2015Radiat Oncol 2015; 10:116
Putora Paul Martin, Stahl Michael, Schnider Annelies, Mariette Christophe, Van Lanschot J Jan B, Jäger Robert, van der Gaast Ate, Eisterer Wolfgang, Budach Wilfried, Bedenne Laurent, Ruhstaller Thomas
Consensus and differences in primary radiotherapy for localized and locally advanced prostate cancer in Switzerland: A survey on patterns of practice
Panje C, Dal Pra A, Zilli T, R Zwahlen D, Papachristofilou A, Herrera F, Matzinger O, Plasswilm L, Putora P. Consensus and differences in primary radiotherapy for localized and locally advanced prostate cancer in Switzerland: A survey on patterns of practice. Strahlenther Onkol 2015; 191:778-86.
19.05.2015Consensus and differences in primary radiotherapy for localized and locally advanced prostate cancer in Switzerland: A survey on patterns of practice
19.05.2015Strahlenther Onkol 2015; 191:778-86
Panje Cédric, Dal Pra Alan, Zilli Thomas, R Zwahlen Daniel, Papachristofilou Alexandros, Herrera Fernanda G, Matzinger Oscar, Plasswilm Ludwig, Putora Paul Martin
Radiochemotherapie beim lokal fortgeschrittenen NSCLC - Update 2015
Glatzer M, Putora P. Radiochemotherapie beim lokal fortgeschrittenen NSCLC - Update 2015. SZO 2015; 4:18-22.
01.04.2015Radiochemotherapie beim lokal fortgeschrittenen NSCLC - Update 2015
01.04.2015SZO 2015; 4:18-22
Glatzer Markus, Putora Paul Martin
Measurements of isocenter path characteristics of the gantry rotation axis with a smartphone application
Schiefer J, Ingulfsen N, Kluckert J, Peters S, Plasswilm L. Measurements of isocenter path characteristics of the gantry rotation axis with a smartphone application. Med Phys 2015; 42:1184-92.
08.03.2015Measurements of isocenter path characteristics of the gantry rotation axis with a smartphone application
08.03.2015Med Phys 2015; 42:1184-92
Schiefer Johann, Ingulfsen Nicholas, Kluckert Jonas, Peters Samuel, Plasswilm Ludwig
Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience
Panje C, Panje T, Putora P, Kim S, Haile S, Aebersold D, Plasswilm L. Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience. Radiat Oncol 2015; 10:47.
22.02.2015Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience
22.02.2015Radiat Oncol 2015; 10:47
Panje Cédric, Panje Thierry, Putora Paul Martin, Kim Suk-Kyum, Haile Sarah, Aebersold Daniel M, Plasswilm Ludwig
Prognostic significance of histology after resection of brain metastases and whole brain radiotherapy in non-small cell lung cancer (NSCLC)
Putora P, ess s, Panje C, Hundsberger T, van Leyen K, Plasswilm L, Früh M. Prognostic significance of histology after resection of brain metastases and whole brain radiotherapy in non-small cell lung cancer (NSCLC). Clin Exp Metastasis 2015; 32:143-9.
28.01.2015Prognostic significance of histology after resection of brain metastases and whole brain radiotherapy in non-small cell lung cancer (NSCLC)
28.01.2015Clin Exp Metastasis 2015; 32:143-9
Putora Paul Martin, ess silvia, Panje Cédric, Hundsberger Thomas, van Leyen Karin, Plasswilm Ludwig, Früh Martin
PSA bounce after 125J-brachytherapy for prostate cancer as a favorable prognosticator
Engeler D, Schmid H, Plasswilm L, Schiefer J, Stucki P, Suter S, Prikler L, Hochreiter W, Thöni A, Schwab C, Putora P. PSA bounce after 125J-brachytherapy for prostate cancer as a favorable prognosticator. Strahlenther Onkol 2015; 191:787-91.
01.01.2015PSA bounce after 125J-brachytherapy for prostate cancer as a favorable prognosticator
01.01.2015Strahlenther Onkol 2015; 191:787-91
Engeler Daniel, Schmid Hans-Peter, Plasswilm Ludwig, Schiefer Johann, Stucki P, Suter S, Prikler L, Hochreiter W, Thöni A, Schwab Christoph, Putora Paul Martin
(Neo-) Adjuvante endokrine Therapie des lokoregionär begrenzten Prostatakarzinoms
Plasswilm L, Schmid H, Schwab C, Putora P. (Neo-) Adjuvante endokrine Therapie des lokoregionär begrenzten Prostatakarzinoms. J Urol Urogynäkol 2015; 22:10-5.
01.01.2015(Neo-) Adjuvante endokrine Therapie des lokoregionär begrenzten Prostatakarzinoms
01.01.2015J Urol Urogynäkol 2015; 22:10-5
Plasswilm Ludwig, Schmid Hans-Peter, Schwab Christoph, Putora Paul Martin
Permanente interstitielle Brachytherapie mit Jod-125
Engeler D, Putora P, Schmid H, Aebersold D. Permanente interstitielle Brachytherapie mit Jod-125. info@onkologie 2015; 5:13-5.
01.01.2015Permanente interstitielle Brachytherapie mit Jod-125
01.01.2015info@onkologie 2015; 5:13-5
Engeler Daniel, Putora Paul Martin, Schmid Hans-Peter, Aebersold DM